cytarabine and Esophageal Squamous Cell Carcinoma

cytarabine has been researched along with Esophageal Squamous Cell Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bi, Y; Cheng, X; Cui, H; Cui, Y; Gao, Y; Guo, M; Kong, P; Li, H; Liu, F; Ma, Y; Niu, X; Qian, Y; Wang, F; Xu, J; Yan, T; Yang, J; Zhang, L; Zhang, X1

Other Studies

1 other study(ies) available for cytarabine and Esophageal Squamous Cell Carcinoma

ArticleYear
TSTA3 facilitates esophageal squamous cell carcinoma progression through regulating fucosylation of LAMP2 and ERBB2.
    Theranostics, 2020, Volume: 10, Issue:24

    Topics: Aged; Animals; Carbohydrate Epimerases; Cell Line, Tumor; Cell Proliferation; Disease Progression; DNA Copy Number Variations; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagus; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glycosylation; Guanosine Diphosphate Fucose; Humans; Ketone Oxidoreductases; Lysosomal-Associated Membrane Protein 2; Male; Mice; Middle Aged; Prognosis; Receptor, ErbB-2; Whole Genome Sequencing; Xenograft Model Antitumor Assays

2020